Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses (Q26853468)

1

1 reference

S. Hierl

2

1 reference

W. Kissling

3

1 reference

J. M. Davis

5

1 reference

language of work or name

1 reference

February 2012

1 reference

British Journal of Psychiatry

published in

1 reference

volume

200

1 reference

issue

2

1 reference

page(s)

97-106

1 reference

Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials

cites work

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Placebo response in studies of major depression: variable, substantial, and growing

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Association between unreported outcomes and effect size estimates in Cochrane meta-analyses

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

A simple method for converting an odds ratio to effect size for use in meta-analysis

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Thrombolysis for acute ischaemic stroke

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Interferon for interferon naive patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Antimicrobial prophylaxis for colorectal surgery

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD)

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Interferon in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Digitalis for treatment of heart failure in patients in sinus rhythm

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Oral sumatriptan for acute migraine

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Metformin monotherapy for type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Inhaled corticosteroids for stable chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Propranolol for migraine prophylaxis

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Medical treatments in the short term management of reflux oesophagitis

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Alpha-glucosidase inhibitors for type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Infliximab for the treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Diuretics for heart failure

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Cholinesterase inhibitors for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-regression analysis.

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Effect sizes in cumulative meta-analyses of mental health randomized trials evolved over time.

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Magnitude of benefit of adjuvant chemotherapy for non-small cell lung cancer: meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Measures of efficiency in healthcare: QALMs about QALYs?

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta-analysis of individual patient data

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Defining 'response' in antipsychotic drug trials: recommendations for the use of scale-derived cutoffs

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Leitlinie der Deutschen Atemwegsliga und der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem (COPD)

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Multivariate meta-analysis of controlled drug studies for obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Magnitude of effect of lithium in short-term efficacy studies of moderate to severe manic episode

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Anticonvulsants in migraine prophylaxis: a Cochrane review.

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

1 reference

7 January 2021

Mood stabilizers in the prevention of recurrent affective disorders: a meta-analysis

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

British Guideline on the Management of Asthma

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Headaches and the Treatment of Blood Pressure

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Antidepressants for bipolar depression: a systematic review of randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

A meta-analysis of the effects of presenting treatment benefits in different formats

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Efficacy of Adderall for Attention-Deficit/Hyperactivity Disorder: a meta-analysis

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Lithium revisited. A re-examination of the placebo-controlled trials of lithium prophylaxis in manic-depressive disorder

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Meta-analysis of randomised controlled trials of fluoxetine v. placebo and tricyclic antidepressants in the short-term treatment of major depression

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Beta-blockers in congestive heart failure. A Bayesian meta-analysis.

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Meta-analysis: angiotensin-receptor blockers in chronic heart failure and high-risk acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021

Meta-analysis: effects of adding salmeterol to inhaled corticosteroids on serious asthma-related events

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.111.096594

7 January 2021